Esomeprazole 40 mg + Domperidone 30 mg
ISROSIGN-D 40 combines Esomeprazole, a potent proton pump inhibitor, with Domperidone, a prokinetic agent. This dual-action formula suppresses excess gastric acid secretion and enhances gastric emptying, offering rapid and sustained relief from reflux-related symptoms.
It is recommended for gastroesophageal reflux disease (GERD), dyspepsia, and other conditions requiring acid suppression and prokinetic therapy.
Each capsule contains:
Esomeprazole 40 mg
Domperidone 30 mg
Proton Pump Inhibitor + Prokinetic Agent
Available in strips of 10 capsules
10 × 10 capsules packaging
Store in a cool, dry place
Protect from light and moisture
Keep out of reach of children
Relief from gastroesophageal reflux disease and acid reflux symptoms
Management of hyperacidity, heartburn, and acid-related dyspepsia
Improvement of gastric emptying and symptom control in dyspepsia
Prevention of nausea and vomiting associated with gastric stasis
The usual adult dose is one capsule once daily before meals or as directed by a physician.
Esomeprazole reduces gastric acid secretion, while Domperidone improves gastric motility and prevents nausea, offering comprehensive symptom relief.
Long-term use should be under strict medical supervision. Your doctor will advise on the duration of treatment based on your condition.
Possible side effects include headache, diarrhea, abdominal pain, or dry mouth. Serious adverse effects are rare but should be reported to a healthcare provider immediately.